26/02/2013

Prostate Cancer Research Begins

Researchers from the University of Ulster have been awarded a £214,000 grant to investigate a new drug combination to help reduce the spread of prostate cancer to other parts of the body.

The team from the Biomedical Sciences Research Institute have been awarded one of 17 Prostate Cancer UK grants as part of the first wave of funding through the charity’s ambitious new research strategy.

As part of its MANifesto, Prostate Cancer UK has pledged to find answers to some of the most important research challenges facing the disease today.

The charity is injecting a colossal £11 million into research this year alone to focus on the key areas of understanding risk, improving diagnosis of the disease and improving treatment options for men living with it.

Dr Iain Frame, Director of Research at Prostate Cancer UK, said: "Due to a long legacy of underfunding and neglect, we still know shockingly little about why prostate cancer kills 10,000 men every year.

"Prostate Cancer UK has vowed to scale up its mission to deliver so much more and so much better for men. By funding ground breaking projects such as this with the UK’s top research scientists we hope to be able to find the answers we so desperately need for the future."

Dr Jenny Worthington, who will lead the team at the University of Ulster said: "Our study aims to improve the treatment of advanced prostate cancer, for which there are currently very few treatments available.

"We will research a new drug combination therapy which aims to specifically target aggressive prostate tumours to control their growth and, most importantly, reduce the number of tumours which form in other areas of the body.

"Ultimately we hope that this Prostate Cancer UK grant will help us create an optimal treatment schedule which significantly reduces the pain and other debilitating side effects men experience, as well as significantly improve life expectancy."

The grants were awarded via a competitive process, and were subject to detailed assessment from external peer reviewers and the Prostate Cancer UK Research Advisory Committee.

All 17 of the projects which are to receive funding were chosen because of their extremely high quality and relevance to men with prostate cancer.

The Biomedical Sciences Research Institute was ranked number one for research power in the last Research Assessment Exercise in the UK.

(GK)

Related Northern Ireland News Stories
Click here for the latest headlines.

15 November 2024
New £4.3m Grant To Boost Business Innovation
Economy Minister Conor Murphy has launched the Business Innovation Grant (BIG), a new £4.3 million initiative designed to stimulate innovation and enhance productivity among Northern Irish businesses. The scheme, developed by Invest Northern Ireland and delivered in partnership with Innovate NI, is open to micro-businesses, sole traders, and SMEs.
19 November 2024
Two Arrested After High-Speed Police Chase In West Belfast
Two men have been arrested following a high-speed police chase in west Belfast early Monday morning. At around 2:30 AM, police spotted a white Volkswagen Golf traveling at excessive speed on the Westlink.
19 November 2019
QUB Shares In £1.25m Cancer Research Funding
Queen's University Belfast is to share in £1.25 million of funding to further prostate cancer research. The money was awarded to local academics and those at The University of Manchester by Prostate Cancer UK and Movember.
29 February 2012
Cancer Charity Launches Urgent Funding Appeal
Northern Ireland charity Men Against Cancer today launched a new funding drive to raise £400,000 which it says is urgently needed to support local research efforts to combat the growing incidence of male cancers - particularly prostate cancer. Around 800 new cases of prostate cancer are diagnosed in Northern Ireland every year.
20 November 2024
Hydebank Wood Prison Praised For 'Model Of Excellence'
Justice Minister Naomi Long has hailed Hydebank Wood Secure College and Women's Prison as a "model of excellence and good practice" following the publication of two positive inspection reports.